Hiranandani Hospital kidney

The COVID-19 pandemic has disrupted healthcare globally, affecting not only the immune system but also exacerbating conditions like end-stage renal disease. Hiranandani Hospital kidney transplant program highlights the challenges faced during the pandemic, where patients were hesitant to seek kidney transplants, leading to worsened conditions and increased dialysis requirements. Despite the risks, the hospital has maintained strict infection control protocols and remains committed to performing kidney transplants safely. Dr. Sujit Chatterjee, CEO of the hospital, emphasizes their role in battling the pandemic, treating numerous COVID cases, and providing essential care to the community.